Full Text View
Tabular View
No Study Results Posted
Related Studies
Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment (PrOMPT)
This study is not yet open for participant recruitment.
Verified March 2011 by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Study NCT01417988   Information provided by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

First Received on July 25, 2011.   Last Updated on August 15, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infection
Tuberculosis
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
HIV Infections
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Mycobacterium Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Experimental: Empiric TB treatment
ART only arm
Sponsors listed in this trial
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
European and Developing Countries Clinical Trials Partnership (EDCTP)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services